No Data
No Data
What Shandong Xinhua Pharmaceutical Company Limited's (HKG:719) P/E Is Not Telling You
Shandong Xinhua Pharmaceutical Achieves Milestone in Generic Drug Approval
Shandong Xinhua Pharmaceutical to Renew License Agreement for Trademark Xinhua
Shandong Xinhua Pharmaceutical Eyes Stake in Nutritional Oil Refining Firm
Express News | Shandong Xinhua Pharmaceutical - Novosanaeuropeb.v. to Sell Not More Than 75% of Novosana (Taicang) Co
Express News | Shandong Xinhua Pharmaceutical - Acquisition Letter of Intent in Relation to Acquisition of a Co
whqqq : Will more capital flow into the Hong Kong market after the delisting crisis?
HopelessChi whqqq : future is solid red. must be some amazing news crashing the future of HSI/HST
whqqq HopelessChi : What's the bad news?
海纳百川 whqqq : It will take longer for the market to recover; currently, it is still mainly bearish
whqqq 海纳百川 : OKAY...Thank you for your answer